European Archives - Page 236 of 1151 - European Medical Journal

Consequences of Disintegrated Care for Dual Tuberculosis and Diabetes

Diabetes is known to be a risk factor for active pulmonary tuberculosis (TB) and the reactivation of latent or previous TB. It is also…

AI and Diabetes Technology in Diabetic Complications

IN AN INSIGHTFUL session presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024, the speakers…

Sex-Specific Differences of Human Skeletal Muscle

Exercise is a potent skeletal muscle stimulus and the most effective strategy to prevent weight loss-related muscle loss and Type 2…

Youth-Onset Type 2 Diabetes: An Awakening Epidemic

THE RISING global prevalence of youth-onset Type 2 diabetes (Y-T2D) is a serious public health concern. With an aggressive clinical course…

EASD 2024 Abstract Highlights

NEW RESEARCH presented at EASD 2024 revealed that maternal Type 1 diabetes (T1D) provides long-term relative protection against the…

EASD 2024 Interview: Francesco Giorgino

I was fascinated by hormones from when I first learnt about hormones as molecules that can carry a signal from one tissue or cell to…

How to maximise your year-end medical affairs and marketing budget

In the final quarter of the year, how can pharmaceutical teams make their final budget decisions count?

Behind the Breakthroughs: Tackling Vasculitis and Emerging Inflammatory Diseases

In this episode, Jonathan is joined by John H. Stone, Professor of Medicine at Harvard Medical School and The Edward A. Fox Chair in Medicine at Massachusetts General Hospital

Methods for Detecting Pancreatic Neoplasms

A novel deep-learning method utilising endoscopic ultrasound images could significantly enhance the detection of pancreatic neuroendocrine neoplasms according to recent research

Handshake on a green background

Merck acquires Modifi Biosciences in $1.3bn cancer therapy deal

The acquisition strengthens Merck’s oncology portfolio as the company looks to off the expiration of the patent for pembrolizumab.